OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Commerce. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
August 16, 2021
How the development of more quantitative and qualitative data around the patient can drive better-informed care decisions—and help avoid potential overstock scenarios that can deplete earnings
July 23, 2021
How pharma’s retooling of its promotional efforts in the post-pandemic era impacts sizing and targeting, two crucial foundational pieces to successful commercialization
July 01, 2021
Arthrex to receive US rights to distribute and commercialize Celularity’s placental-derived biomaterial products for orthopedics and sports medicine
June 17, 2021
A conversation with Vin Colicchio, vice president, supply chain and external manufacturing, Dr. Reddy’s Laboratories
March 19, 2021
A well-oiled, data-driven hub program is critical for stakeholders in supporting patients—and clearing a successful path for specialty therapies
March 18, 2021
A conversation with Cathy Traz, global advocacy head at Bristol Myers Squibb
February 17, 2021
Covid-19 reveals how important field reps will be to driving digital adoption
December 18, 2020
Embracing AI 2.0 and modern machine learning as foundational tools to deepening HCP engagement
Using technology to enable processes, drive cost savings, and deliver better patient outcomes
Are regulations hindering pharma innovations?